The Claim
In rats with bilateral carotid artery occlusion and reperfusion, local administration of BPC 157 during reperfusion is associated with unchanged expression of Mapk1 mRNA.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats subjected to restricted blood flow and restored circulation in the brain, injecting BPC 157 at the time of blood flow restoration does not change the activity level of the Mapk1 gene.
See the scientific wording
In rats with bilateral carotid artery occlusion and reperfusion, BPC 157 administered locally during reperfusion is associated with unchanged expression of Mapk1 mRNA, suggesting this pathway is not a primary mediator of its observed neuroprotective effects.
A peptide called BPC 157 binds to a receptor on blood vessel and nerve cells, turning on a survival signal that boosts protective nitric oxide production while blocking harmful inflammation. This reduces cell damage and death in the brain after blood flow is restored, without affecting a gene called Mapk1.
What the research says
1 studyStudy: The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
In rats with brain injury from blocked blood flow, a peptide called BPC 157 helped them recover without changing the activity of a gene called Mapk1 — meaning Mapk1 wasn’t responsible for the healing.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.